Knight Therapeutics | GUD - PE Price to Earnings

Stock Price
5.84
Daily Change
-0.05 -0.85%
Monthly
-1.02%
Yearly
1.57%
Q1 Forecast
5.66

Knight Therapeutics reported CAD91.09 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Acasti Pharma USD 9.94 0.08 Mar/2021
Aurora Cannabis CAD 23.27 0 Sep/2025
Cronos Group USD 21.37 7.75 Sep/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
IQVIA Holdings USD 26.59 2.03 Dec/2025
Knight Therapeutics CAD 91.09 0.73 Sep/2025
Moderna USD 27.22 14.51 Jun/2023
Organigram Holdings CAD 235 224.49 Sep/2025
Organon & Co USD 4.62 2.04 Sep/2025
Revvity USD 33.29 4.58 Sep/2025
Tectonic Therapeutic USD 4.01 0.63 Mar/2024
Viatris USD 10.4 11.84 Sep/2025